1. Home
  2. INCR vs PFX Comparison

INCR vs PFX Comparison

Compare INCR & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INCR
  • PFX
  • Stock Information
  • Founded
  • INCR 1994
  • PFX 2010
  • Country
  • INCR Israel
  • PFX United States
  • Employees
  • INCR N/A
  • PFX N/A
  • Industry
  • INCR Biotechnology: Pharmaceutical Preparations
  • PFX Finance: Consumer Services
  • Sector
  • INCR Health Care
  • PFX Finance
  • Exchange
  • INCR Nasdaq
  • PFX Nasdaq
  • Market Cap
  • INCR 83.5M
  • PFX 96.4M
  • IPO Year
  • INCR N/A
  • PFX N/A
  • Fundamental
  • Price
  • INCR $1.57
  • PFX $47.78
  • Analyst Decision
  • INCR
  • PFX
  • Analyst Count
  • INCR 0
  • PFX 0
  • Target Price
  • INCR N/A
  • PFX N/A
  • AVG Volume (30 Days)
  • INCR 131.9K
  • PFX 846.0
  • Earning Date
  • INCR 08-28-2025
  • PFX 08-06-2025
  • Dividend Yield
  • INCR N/A
  • PFX 3.03%
  • EPS Growth
  • INCR N/A
  • PFX N/A
  • EPS
  • INCR N/A
  • PFX 3.06
  • Revenue
  • INCR $65,575,323.00
  • PFX $23,958,590.00
  • Revenue This Year
  • INCR $69.54
  • PFX $10.24
  • Revenue Next Year
  • INCR $41.75
  • PFX N/A
  • P/E Ratio
  • INCR N/A
  • PFX $15.45
  • Revenue Growth
  • INCR N/A
  • PFX 7.47
  • 52 Week Low
  • INCR $1.17
  • PFX $44.56
  • 52 Week High
  • INCR $1.87
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • INCR 57.02
  • PFX 45.16
  • Support Level
  • INCR $1.40
  • PFX $47.20
  • Resistance Level
  • INCR $1.65
  • PFX $48.45
  • Average True Range (ATR)
  • INCR 0.06
  • PFX 0.25
  • MACD
  • INCR 0.01
  • PFX -0.00
  • Stochastic Oscillator
  • INCR 81.11
  • PFX 51.55

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: